怎么加杠杆买股票百度搜加杠网-股市明天走势最新消息-【东方资本】,股票做t举例子,亿赢集团有限公司,适合长线的股票推介

"Biodegradable coronary stents (xinsorb)" is a project independently developed by our company. The core of the project is new material research and application technology, involving biopharmaceutical research, solid mechanics research, medical clinical experiment and the production of implantable medical devices.

After eight years of hard work, we have overcome many technical difficulties and mastered the core technology of only a few companies in the world. We have successfully developed the "biodegradable coronary rapamycin eluting stent system" (xinsorb stent), which is the first in China and has the world leading level. The fourth development of percutaneous coronary intervention is known as the fourth development of bare metal stent.